High Performance for Unprecedented Reliability and Throughput

The TOKYO platform, combined with MIVO®, allows for the most relevant and reliable exploratory and preclinical assays with an unprecedented level of throughput in a millifluidic system.

Overcoming the Limits of Existing Platforms

Current high-throughput platforms are static, limiting their use for complex disease models, cell therapy, and immunotherapy testing, where immune cells need to be cultured in a dynamic flow, as in vivo, to obtain reliable results. TOKYO is the only flow system that combines high experiment throughput with maximum result reliability.

MIVO technology inside tokyo millifludic device react for life

MIVO® technology, combined with the Tokyo platform, enables the study of human biology, both in physiological and pathological conditions, under controlled culture of cells and tissues, enhancing the predictivity and reliability of results.
With MIVO® platform, researchers can deeply understand human diseases mechanisms and progression and also test new compounds and personalized therapies.

Advanced Technical Features

Up to 24 experiment lines
Swift Tube Locking System
Compact design
Physiological flow velocities
Intuitive external control
Efficient tray
Universal incubator compatibility

Physiological Flow Velocities

Discover the Power of Millifluidics with the Tokyo Platform

The Tokyo platform recreates microenvironments that more accurately mimic human biological conditions, offering unparalleled precision and control over the fluid flows. Its innovative design enhances the accuracy of drug testing and cellular studies, paving the way for breakthroughs in personalized medicine.